MALIBU, CA – September 16, 2026 – PRESSADVANTAGE – ...

FAYUVI is a highly anticipated, first-ever treatment option with the potential to stop or slow the devastating, irreversible neurologic ...

A recovery campus operated by St. Joseph’s Addiction Treatment & Recovery Centers officially opened its doors with a ...

By Sriparna Roy and Kamal Choudhury Sept 17 (Reuters) - Ultragenyx Pharmaceutical said on Thursday it has set a U.S. list price of $3.95 million for its newly approved gene therapy Fayuvi, launching ...

Good afternoon, and welcome to the Ultragenyx Pharmaceutical conference call to discuss the U.S. Food and Drug Administration approval of the FAYUVI for the treatment of the MPS IIIA, also known as ...

The agency has lost count of miscarriages amid record-high pregnant detainees and reports of denial of medical care ...

FAYUVI is a highly anticipated, first-ever treatment option with the potential to stop or slow the devastating, irreversible neurologic progression and loss of function associated with Sanfilippo synd ...

The first patients were dosed in the global phase 3 ORBIT pivotal trial of linsitinib for thyroid eye disease (TED). The first patients were dosed in the global phase 3 ORBIT trial evaluating ...

More than 20% of participating comprehensive cancer centers in the US report a shortage of 5 or more cancer treatment medications.

Chronic kidney disease might sound alarming, but it doesn't always lead to kidney failure. With timely diagnosis and ...

Over 30 people across four states have been poisoned by bacterial toxins after getting intravenous (IV) drips at wellness ...

The Centers for Disease Control and Prevention and the San Diego County Health Department are conducting a follow-up door-to-door health survey in Imperial Beach to assess the ongoing impacts of the ...